 Bhupendar Tayal
Concepts (156)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Resynchronization Therapy | 16 | 2021 | 21 | 4.800 |
Why?
| | Heart Failure | 18 | 2023 | 531 | 4.240 |
Why?
| | Echocardiography | 14 | 2024 | 409 | 2.770 |
Why?
| | Atrial Fibrillation | 6 | 2023 | 197 | 1.810 |
Why?
| | Mitral Valve Insufficiency | 3 | 2024 | 56 | 1.660 |
Why?
| | Magnetic Resonance Imaging, Cine | 3 | 2024 | 64 | 1.630 |
Why?
| | Stroke Volume | 11 | 2024 | 150 | 1.520 |
Why?
| | Registries | 10 | 2024 | 652 | 1.510 |
Why?
| | Heart Atria | 2 | 2024 | 64 | 1.480 |
Why?
| | Pacemaker, Artificial | 3 | 2023 | 42 | 1.390 |
Why?
| | Heart Ventricles | 7 | 2021 | 260 | 1.340 |
Why?
| | Bundle-Branch Block | 7 | 2021 | 18 | 1.260 |
Why?
| | Arrhythmias, Cardiac | 3 | 2019 | 98 | 1.210 |
Why?
| | Heart Rate | 4 | 2021 | 314 | 1.210 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2021 | 107 | 1.210 |
Why?
| | Tachycardia, Ventricular | 2 | 2021 | 44 | 1.140 |
Why?
| | Cardiac Pacing, Artificial | 3 | 2023 | 32 | 1.120 |
Why?
| | Cardiomyopathies | 3 | 2024 | 120 | 1.100 |
Why?
| | Denmark | 10 | 2024 | 23 | 1.060 |
Why?
| | Electrocardiography | 10 | 2021 | 273 | 0.950 |
Why?
| | Myocardial Infarction | 4 | 2023 | 445 | 0.890 |
Why?
| | Ventricular Remodeling | 7 | 2023 | 66 | 0.880 |
Why?
| | Atrial Function, Left | 1 | 2024 | 5 | 0.850 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2024 | 32 | 0.850 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2023 | 28 | 0.810 |
Why?
| | Ventricular Function, Left | 9 | 2023 | 178 | 0.780 |
Why?
| | Aged | 27 | 2024 | 10429 | 0.780 |
Why?
| | Coronary Vessels | 2 | 2024 | 170 | 0.760 |
Why?
| | Echocardiography, Doppler | 3 | 2020 | 56 | 0.740 |
Why?
| | Myocarditis | 1 | 2021 | 52 | 0.670 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2021 | 34 | 0.660 |
Why?
| | Population Surveillance | 1 | 2021 | 164 | 0.660 |
Why?
| | Follow-Up Studies | 10 | 2024 | 2318 | 0.650 |
Why?
| | Humans | 46 | 2024 | 53230 | 0.640 |
Why?
| | Middle Aged | 24 | 2024 | 13419 | 0.630 |
Why?
| | Hemodynamics | 1 | 2021 | 236 | 0.610 |
Why?
| | Hyperthyroidism | 1 | 2019 | 28 | 0.600 |
Why?
| | Hypothyroidism | 1 | 2019 | 58 | 0.570 |
Why?
| | Aortic Valve Insufficiency | 3 | 2023 | 25 | 0.560 |
Why?
| | Prospective Studies | 10 | 2024 | 2411 | 0.500 |
Why?
| | Risk Assessment | 4 | 2022 | 1368 | 0.500 |
Why?
| | Male | 29 | 2024 | 27435 | 0.500 |
Why?
| | Female | 30 | 2024 | 28782 | 0.490 |
Why?
| | Predictive Value of Tests | 9 | 2022 | 934 | 0.480 |
Why?
| | Prognosis | 5 | 2021 | 2118 | 0.480 |
Why?
| | Heart Diseases | 1 | 2018 | 221 | 0.480 |
Why?
| | Coronary Artery Disease | 3 | 2024 | 324 | 0.460 |
Why?
| | Echocardiography, Three-Dimensional | 3 | 2022 | 15 | 0.450 |
Why?
| | Gadolinium | 4 | 2023 | 47 | 0.420 |
Why?
| | Survival Rate | 5 | 2021 | 949 | 0.410 |
Why?
| | Contrast Media | 4 | 2023 | 178 | 0.390 |
Why?
| | Incidence | 4 | 2021 | 1085 | 0.380 |
Why?
| | Cicatrix | 3 | 2023 | 43 | 0.380 |
Why?
| | Treatment Outcome | 12 | 2023 | 5595 | 0.380 |
Why?
| | Stroke | 3 | 2023 | 520 | 0.370 |
Why?
| | Patient Selection | 3 | 2019 | 273 | 0.350 |
Why?
| | Aortic Valve Stenosis | 2 | 2023 | 79 | 0.340 |
Why?
| | Myocardial Contraction | 3 | 2019 | 109 | 0.310 |
Why?
| | Coronary Angiography | 3 | 2024 | 369 | 0.270 |
Why?
| | Risk Factors | 8 | 2023 | 4017 | 0.270 |
Why?
| | Comorbidity | 3 | 2019 | 638 | 0.260 |
Why?
| | Heart Valve Prosthesis Implantation | 3 | 2023 | 103 | 0.250 |
Why?
| | Time Factors | 5 | 2021 | 2991 | 0.250 |
Why?
| | Case-Control Studies | 2 | 2019 | 1212 | 0.240 |
Why?
| | Primary Health Care | 2 | 2021 | 404 | 0.240 |
Why?
| | Evidence-Based Medicine | 2 | 2017 | 275 | 0.220 |
Why?
| | Aged, 80 and over | 6 | 2024 | 3494 | 0.220 |
Why?
| | Hypertension, Pulmonary | 2 | 2016 | 102 | 0.210 |
Why?
| | Sinus of Valsalva | 1 | 2024 | 8 | 0.210 |
Why?
| | Atrioventricular Block | 1 | 2023 | 5 | 0.210 |
Why?
| | Acute Disease | 2 | 2021 | 393 | 0.200 |
Why?
| | Radiation Dosage | 1 | 2024 | 160 | 0.200 |
Why?
| | Takotsubo Cardiomyopathy | 1 | 2023 | 23 | 0.200 |
Why?
| | Educational Status | 1 | 2024 | 229 | 0.200 |
Why?
| | Ischemic Attack, Transient | 1 | 2023 | 59 | 0.200 |
Why?
| | Aortic Valve | 2 | 2023 | 130 | 0.190 |
Why?
| | Thromboembolism | 1 | 2022 | 48 | 0.180 |
Why?
| | Pennsylvania | 3 | 2016 | 29 | 0.180 |
Why?
| | Liver Diseases | 1 | 2022 | 81 | 0.180 |
Why?
| | Hospitalization | 2 | 2023 | 749 | 0.170 |
Why?
| | Brain Ischemia | 1 | 2022 | 162 | 0.160 |
Why?
| | Heart Conduction System | 1 | 2020 | 25 | 0.160 |
Why?
| | Retrospective Studies | 6 | 2023 | 6819 | 0.160 |
Why?
| | Stress, Mechanical | 1 | 2021 | 95 | 0.160 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2020 | 42 | 0.160 |
Why?
| | Causality | 2 | 2016 | 53 | 0.160 |
Why?
| | Longitudinal Studies | 3 | 2016 | 774 | 0.160 |
Why?
| | Pulmonary Embolism | 1 | 2020 | 83 | 0.150 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2019 | 21 | 0.150 |
Why?
| | Pneumonectomy | 1 | 2019 | 29 | 0.150 |
Why?
| | Atrial Appendage | 1 | 2019 | 15 | 0.150 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2020 | 136 | 0.150 |
Why?
| | Pulmonary Artery | 1 | 2020 | 142 | 0.150 |
Why?
| | Hypertension | 1 | 2024 | 554 | 0.150 |
Why?
| | Heart Arrest | 1 | 2020 | 144 | 0.140 |
Why?
| | Echocardiography, Transesophageal | 1 | 2019 | 63 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 3 | 2020 | 1583 | 0.140 |
Why?
| | Adult | 5 | 2024 | 14534 | 0.130 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 1723 | 0.130 |
Why?
| | Myocardial Revascularization | 3 | 2024 | 29 | 0.130 |
Why?
| | Prevalence | 2 | 2016 | 1034 | 0.120 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 205 | 0.120 |
Why?
| | Exercise | 1 | 2021 | 561 | 0.120 |
Why?
| | Ventricular Dysfunction | 1 | 2016 | 11 | 0.120 |
Why?
| | Postoperative Complications | 2 | 2023 | 1099 | 0.120 |
Why?
| | Time | 1 | 2015 | 28 | 0.120 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2016 | 98 | 0.110 |
Why?
| | Myocardial Stunning | 1 | 2014 | 2 | 0.110 |
Why?
| | Computer Simulation | 1 | 2015 | 290 | 0.110 |
Why?
| | Observer Variation | 3 | 2022 | 138 | 0.100 |
Why?
| | Cohort Studies | 3 | 2023 | 1557 | 0.100 |
Why?
| | Reproducibility of Results | 3 | 2024 | 1219 | 0.100 |
Why?
| | Proportional Hazards Models | 2 | 2020 | 445 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2018 | 867 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2020 | 1049 | 0.050 |
Why?
| | Tin | 1 | 2024 | 1 | 0.050 |
Why?
| | Vascular Calcification | 1 | 2024 | 22 | 0.050 |
Why?
| | Sick Sinus Syndrome | 1 | 2023 | 3 | 0.050 |
Why?
| | Bradycardia | 1 | 2023 | 38 | 0.050 |
Why?
| | Syncope | 1 | 2023 | 31 | 0.050 |
Why?
| | Aorta, Thoracic | 1 | 2024 | 101 | 0.050 |
Why?
| | Hypertrophy | 1 | 2023 | 53 | 0.050 |
Why?
| | Aorta | 1 | 2024 | 172 | 0.050 |
Why?
| | Fibrosis | 1 | 2023 | 198 | 0.050 |
Why?
| | Vitamin K | 1 | 2022 | 17 | 0.050 |
Why?
| | Sex Characteristics | 1 | 2023 | 204 | 0.040 |
Why?
| | Hemorrhage | 1 | 2022 | 226 | 0.040 |
Why?
| | Athletes | 1 | 2021 | 104 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2020 | 38 | 0.040 |
Why?
| | Arterial Pressure | 1 | 2020 | 44 | 0.040 |
Why?
| | Cardiovascular Agents | 1 | 2020 | 66 | 0.040 |
Why?
| | Cause of Death | 1 | 2020 | 156 | 0.040 |
Why?
| | Defibrillators, Implantable | 1 | 2020 | 62 | 0.040 |
Why?
| | Survivors | 1 | 2020 | 120 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2021 | 411 | 0.040 |
Why?
| | Anticoagulants | 1 | 2022 | 280 | 0.040 |
Why?
| | Echocardiography, Doppler, Pulsed | 1 | 2018 | 7 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 1 | 2024 | 1180 | 0.040 |
Why?
| | Heart Valve Diseases | 1 | 2019 | 55 | 0.040 |
Why?
| | Systole | 1 | 2018 | 71 | 0.040 |
Why?
| | Chronic Disease | 1 | 2020 | 580 | 0.030 |
Why?
| | Recovery of Function | 1 | 2018 | 203 | 0.030 |
Why?
| | Retreatment | 1 | 2016 | 60 | 0.030 |
Why?
| | Action Potentials | 1 | 2016 | 116 | 0.030 |
Why?
| | Disease Progression | 1 | 2018 | 880 | 0.030 |
Why?
| | Algorithms | 1 | 2018 | 667 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 487 | 0.030 |
Why?
| | Infant | 1 | 2023 | 3805 | 0.030 |
Why?
| | Heart-Assist Devices | 1 | 2016 | 157 | 0.030 |
Why?
| | Echocardiography, Stress | 1 | 2014 | 9 | 0.030 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2014 | 17 | 0.030 |
Why?
| | Patient Readmission | 1 | 2016 | 251 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2014 | 129 | 0.020 |
Why?
| | Positron-Emission Tomography | 1 | 2014 | 298 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2016 | 327 | 0.020 |
Why?
| | Myocardium | 1 | 2014 | 471 | 0.020 |
Why?
|
|
Tayal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|